10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:178
Name:Compound 178
Description:Original numeration in publication: 18
Labels:Training_set, Thiazolidine-2, 4-dione
CAS:
InChi Code:InChI=1S/C27H19Cl2N3O6S/c1-38-26(36)16-5-10-20(11-6-16)31-24(34)15-3-8-19(9-4-15)30-23(33)14-32-25(35)22(39-27(32)37)12-17-2-7-18(28)13-21(17)29/h2-13H,14H2,1H3,(H,30,33)(H,31,34)/b22-12-

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
6.77

El-Adl, K.; El-Helby, A.-G. A.; Sakr, H. a. A., R. R.; Mahdy, H. A.; Nasser, M. a. A., H. S.; El-Hddad, S. S. A. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000279. https://doi.org/10.1002/ardp.202000279

6.37789

Eq1: VEGFR-2 inhibition (Data used to train model)